International Journal Of Clinical Therapeutics And Medical Research • pp. 1-12
ADVANCES IN TARGETED DRUG DELIVERY SYSTEMS FOR IMPROVING THERAPEUTIC OUTCOMES IN CHRONIC DISEASES
Abstract
Targeted drug delivery systems have emerged as an important advancement in modern pharmaceutical science,
offering opportunities to improve the effectiveness, safety, and precision of treatment for chronic diseases.
Conventional drug administration often distributes therapeutic agents throughout the body, which may result in
limited drug accumulation at the intended site, reduced therapeutic effectiveness, and unwanted adverse effects in
healthy tissues. Targeted drug delivery systems are designed to transport medications toward specific organs,
tissues, cells, or biological pathways, thereby improving drug availability at the required therapeutic location.
Recent developments in nanotechnology, liposomes, polymeric nanoparticles, lipid-based carriers, micelles,
hydrogels, and stimuli-responsive materials have expanded the possibilities of controlled and site-specific drug
administration. These technologies are particularly relevant to chronic conditions such as cancer, diabetes,
cardiovascular diseases, rheumatoid arthritis, and chronic inflammatory disorders, which frequently require longterm treatment and careful medication management. This research examines the major types, mechanisms, clinical
applications, and therapeutic advantages of targeted drug delivery systems in chronic disease management. It also
explores limitations involving biological barriers, drug stability, toxicity, manufacturing complexity, affordability,
and clinical translation. A qualitative descriptive methodology is adopted through the analysis of existing scientific
literature and relevant pharmaceutical research. The findings indicate that targeted delivery platforms can improve
drug distribution, support controlled release, and reduce certain treatment-related adverse effects. However, their
clinical performance depends on disease characteristics, carrier design, biological compatibility, and the ability to
achieve consistent drug delivery in human patients. The study concludes that targeted drug delivery systems offer
significant potential for improving therapeutic outcomes, but further clinical research, standardized manufacturing,
regulatory evaluation, and cost-effective development are necessary to establish their wider role in chronic disease
treatment.
Record
- Identifier
- https://doi-services.com/1168/305
- Published
- 2026-03-16
- Version
- 1